Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 10, Number 29, November 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book review

Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
pp. i-i(1)
Author: Lip, Gregory Y.H.

Review article

Drug Development and the Importance of Ethnicity: Lessons from Heart Failure Management and Implications for Hypertension
pp. 3569-3577(9)
Authors: Sosin, Michael D.; Bhatia, Gurbir S.; Lip, Gregory Y.H.; Davis, Russell C.

Sympathetic and Baroreflex Function in Hypertension: Implications for Current and New Drugs
pp. 3579-3589(11)
Author: Grassi, Guido

Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
pp. 3591-3605(15)
Authors: Nadar, Sunil; Blann, Andrew D.; Lip, Gregory Y.H.

Antihypertensive Therapy and Endothelial Function
pp. 3607-3614(8)
Authors: Nadar, Sunil; Blann, Andrew D.; Lip, Gregory Y.H.

Hypertension in Peripheral Arterial Disease
pp. 3615-3620(6)
Authors: Clement, Denis L.; De Buyzere, Marc L.; Duprez, Daniel A.

Pathophysiology and Treatment of Obesity Hypertension
pp. 3621-3637(17)
Authors: Wofford, Marion R.; Hall, John E.

Propofol: Therapeutic Indications and Side-Effects
pp. 3639-3649(11)
Author: Marik, Paul E.

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents
pp. 3651-3662(12)
Authors: Green, Brian D.; Gault, Victor A.; O'Harte, Finbarr P.M.; Flatt, Peter R.

In Utero Gene Therapy: Prospect and Future
pp. 3663-3672(10)
Authors: Chauhan, D. P.; Srivastava, A. S.; Moustafa, M. E.; Shenouda, S.; Carrier, E.

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies
pp. 3673-3681(9)
Authors: Secchiero, Paola; Vaccarezza, Mauro; Gonelli, Arianna; Zauli, Giorgio

Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
pp. 3683-3695(13)
Author: Cellek, S.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A